USFDA gives approval for this Skin and Bone Infections Drug

This drug is used to treat infections such as those of the skin and bones

65
USFDA Approval

Last Updated on August 14, 2023 by The Health Master

Aurobindo Pharma Ltd. has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Vancomycin Hydrochloride, a drug that is used to treat infections such as those of the skin and bones.

The approval was granted by the USFDA to Eugia Pharma Specialities Ltd., a wholly owned subsidiary of the company.

Vancomycin Hydrochloride, for injections, is supplied in single-dose vials of 1.25 grams and 1.5 grams, the company said in a press release.

Vancomycin Hydrochloride is used to treat septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract Infections, it said.

Types of inspections done by USFDA: Read in detail

USFDA issues Form 483 to Pharma Companies: Let’s know all about it

Understanding GMP, cGMP, and WHO-GMP

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news